Literature DB >> 8232951

Contrast sensitivity dysfunction in Alzheimer's disease.

J T Hutton1, J L Morris, J W Elias, J N Poston.   

Abstract

We compared the spatial contrast sensitivity of six patients with mild to moderate Alzheimer's disease (AD) and six age-matched control subjects in a parametric design. Results demonstrate reduced contrast sensitivity in patients with AD at all but the lowest frequency tested. The results suggest that the effect of AD on spatial contrast sensitivity is stronger at higher frequencies and provide a rationale for complaints of poor vision in AD patients.

Entities:  

Mesh:

Year:  1993        PMID: 8232951     DOI: 10.1212/wnl.43.11.2328

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

Review 1.  Visual spatial cognition in neurodegenerative disease.

Authors:  Katherine L Possin
Journal:  Neurocase       Date:  2010-06-02       Impact factor: 0.881

2.  Reduced contrast sensitivity among older women is associated with increased risk of cognitive impairment.

Authors:  Michael E Ward; Jeffrey M Gelfand; Li-Yung Lui; Yvonne Ou; Ari J Green; Katie Stone; Kathryn L Pedula; Steven R Cummings; Kristine Yaffe
Journal:  Ann Neurol       Date:  2018-04-11       Impact factor: 10.422

3.  Neuroanatomical substrates underlying contrast sensitivity.

Authors:  Ying Yang; Yajun Wang; Cun Zhang; Jiajia Zhu; Yongqiang Yu
Journal:  Quant Imaging Med Surg       Date:  2019-03

4.  Ocular manifestations of Alzheimer's disease in animal models.

Authors:  Miles Parnell; Li Guo; Mohamed Abdi; M Francesca Cordeiro
Journal:  Int J Alzheimers Dis       Date:  2012-05-15

5.  Ophthalmologic Psychophysical Tests Support OCT Findings in Mild Alzheimer's Disease.

Authors:  Elena Salobrar-Garcia; Rosa de Hoz; Blanca Rojas; Ana I Ramirez; Juan J Salazar; Raquel Yubero; Pedro Gil; Alberto Triviño; José M Ramirez
Journal:  J Ophthalmol       Date:  2015-05-27       Impact factor: 1.909

6.  Optical Coherence Tomography in Alzheimer's Disease: A Meta-Analysis.

Authors:  Gianluca Coppola; Antonio Di Renzo; Lucia Ziccardi; Francesco Martelli; Antonello Fadda; Gianluca Manni; Piero Barboni; Francesco Pierelli; Alfredo A Sadun; Vincenzo Parisi
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

7.  Human Tau Expression Does Not Induce Mouse Retina Neurodegeneration, Suggesting Differential Toxicity of Tau in Brain vs. Retinal Neurons.

Authors:  Léa Rodriguez; Julius Baya Mdzomba; Sandrine Joly; Mélissa Boudreau-Laprise; Emmanuel Planel; Vincent Pernet
Journal:  Front Mol Neurosci       Date:  2018-08-24       Impact factor: 5.639

8.  Changes in visual function and retinal structure in the progression of Alzheimer's disease.

Authors:  Elena Salobrar-García; Rosa de Hoz; Ana I Ramírez; Inés López-Cuenca; Pilar Rojas; Ravi Vazirani; Carla Amarante; Raquel Yubero; Pedro Gil; María D Pinazo-Durán; Juan J Salazar; José M Ramírez
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

9.  Alzheimer's disease: screening biomarkers using frequency doubling technology visual field.

Authors:  Denise A Valenti
Journal:  ISRN Neurol       Date:  2013-09-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.